Grants and Contributions:
Title:
228007
Agreement Number:
228007
Agreement Value:
$1,000,000.00
Agreement Date:
Apr 27, 2026 - Aug 31, 2027
Description:
Acquire advanced manufacturing equipment to enhance productivity
Organization:
Atlantic Canada Opportunities Agency
Expected Results:
To achieve one or more of the following departmental results, i) Businesses are innovative and growing in Atlantic Canada, ii) Businesses invest in the development and commercialization of innovative technologies in Atlantic Canada; and iii) Communities are economically diversified in Atlantic Canada.
Location:
Mulgrave, Nova Scotia, CA B0E 2G0
Reference Number:
276-2026-2027-Q1-00046
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719101156
Recipient Type:
For-profit organization
Additional Information:
The assistance type is Non-Repayable Contribution.
Recipient's Legal Name:
KD Pharma Canada Ltd.
Program:
REGI-BSP-Regional Tariff Response Initiative (RTRI)
Program Purpose:
To invest in and support businesses at various stages of development, including high-growth firms to accelerate their growth and assist them in scaling up, enhance their productivity and competitiveness in both domestic and global markets.